Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2009
08/19/2009CN100528869C Silybin flavonolignan and their production method and use
08/19/2009CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/19/2009CN100528834C Pharmaceutical compounds
08/19/2009CN100528242C Radioactive macroaggregate and its preparation method
08/19/2009CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/19/2009CN100528206C Jingangteng solution type solid dispersion, and application
08/19/2009CN100528197C Chinese medicinal electuary for treating ankylosing spondylitis
08/19/2009CN100528195C Preparation of dyers woad root injection
08/19/2009CN100528182C Long acting, pain stopping liquor and its preparation process
08/19/2009CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process
08/19/2009CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
08/19/2009CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases
08/19/2009CN100528156C Prevention of addiction in pain management
08/19/2009CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use
08/19/2009CN100528149C A composition for treating neurocerebrovascular disorders
08/19/2009CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process
08/19/2009CN100528144C Aceclofenac in extended-released tablets and method of manufacturing the same
08/18/2009US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent
08/18/2009US7576234 Synthesis of 2-alkyl amino acids
08/18/2009US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer
08/18/2009US7576178 DADD, death activator death domain protein
08/18/2009US7576129 Carboxylic acid compounds
08/18/2009US7576117 Cyclic amine CCR3 antagonist
08/18/2009US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors
08/18/2009US7576105 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
08/18/2009US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases
08/18/2009US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/18/2009US7576097 Crystalline form of maraviroc
08/18/2009US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption
08/18/2009CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
08/18/2009CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use
08/18/2009CA2393568C Diarylmethylpiperazines
08/18/2009CA2335250C Temperature-sensitive liposomal formulation
08/18/2009CA2276764C Acridine derivatives as opioid analgesics
08/18/2009CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product
08/13/2009WO2009100380A1 Use of ranolazine for treating pain
08/13/2009WO2009100335A1 Phosphate derivatives of substituted benzoxazoles
08/13/2009WO2009100171A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/13/2009WO2009100170A1 Dual pharmacophores - pde4-muscarinic antagonistics
08/13/2009WO2009100118A1 Extended release hydrocodone acetaminophen and related methods and uses thereof
08/13/2009WO2009100095A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
08/13/2009WO2009099840A2 Methods of manufacture of morinda citrifolia based compositions for treatment of anti-inflammatory diseases through inhibition of cox-1, cox-2, interleukin-1beta, interleukin-6, tnf-alpha, hle, and inos
08/13/2009WO2009099642A2 Proteomic analysis of active multiple sclerosis lesions
08/13/2009WO2009099147A1 Il-1 type ii receptor gene-deficient mutant of mouse
08/13/2009WO2009099086A1 3-substituted sulfonyl piperazine derivative
08/13/2009WO2009098901A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009WO2009098282A1 Low molecular weight 2,5-disubstituted thiophene derivatives and use thereof in therapy
08/13/2009WO2009098238A1 Anti-trka antibodies and derivatives thereof
08/13/2009WO2009097695A1 Arylmethylidene heterocycles as novel analgesics
08/13/2009WO2009077635A3 Anti-inflammatory, anti-edematous and anti-erythematous composition, method for obtaining same and use thereof
08/13/2009WO2009064457A3 Corticosteroid compositions
08/13/2009WO2009062132A3 Immunomodulating compounds and related compositions and methods
08/13/2009WO2009052972A3 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
08/13/2009WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent
08/13/2009WO2009043453A3 Use of a peptide as a therapeutic agent
08/13/2009WO2009034475A3 Perharidines as cdk inhibitors
08/13/2009WO2009020683A3 Quinazoline compounds
08/13/2009WO2008108958A8 Benzimidazole derivatives and methods of use thereof
08/13/2009US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease
08/13/2009US20090203798 Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol
08/13/2009US20090203782 Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders
08/13/2009US20090203776 Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects
08/13/2009US20090203767 Inhibition stat-1
08/13/2009US20090203764 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
08/13/2009US20090203761 Process for preparing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
08/13/2009US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
08/13/2009US20090203739 Anti-Inflammatory Agents
08/13/2009US20090203732 Thiazolones for Use as P13 Kinase Inhibitors
08/13/2009US20090203711 Inhibitors of P38 Map Kinase
08/13/2009US20090203702 INHIBITORS OF p38
08/13/2009US20090203698 Compounds for Enzyme Inhibition
08/13/2009US20090203695 Compounds IV
08/13/2009US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases
08/13/2009US20090203680 In vivo studies of crystalline forms of meloxicam
08/13/2009US20090203672 Substituted Sulfonamide Compounds
08/13/2009US20090203655 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
08/13/2009US20090203652 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
08/13/2009US20090203620 Methods for attenuating release of inflammatory mediators and peptides useful therein
08/13/2009US20090203616 Methods for treating pain and screening analgesic compounds
08/13/2009US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases
08/13/2009US20090203584 Peptide-based Compounds
08/13/2009US20090202611 Composite self-cohered web materials
08/13/2009US20090202591 Leucine-based motif and clostridial neurotoxins
08/13/2009US20090202522 Use of goat serum for veterinary treatment
08/13/2009US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma
08/13/2009US20090202474 Expression of orphan gpr64 in inflammatory diseases
08/13/2009US20090202469 Detection of inflammatory disease and composition for preventing or treatment of inflammatory disease
08/13/2009US20090202463 Antimicrobial compositions, products and methods employing same
08/13/2009US20090202436 Bupivacaine Formulation in a Polyorthoester Carrier
08/13/2009CA2714966A1 Arylmethylidene heterocycles as novel analgesics
08/13/2009CA2714480A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009CA2714420A1 Phosphate derivatives of substituted benzoxazoles
08/13/2009CA2714398A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
08/13/2009CA2714378A1 Treatment of chronic pain with zinc finger proteins
08/13/2009CA2713786A1 Anti trka antibodies and derivatives thereof
08/13/2009CA2713521A1 Use of ranolazine for treating pain
08/13/2009CA2713447A1 Extended release hydrocodone acetaminophen and related methods and uses thereof
08/13/2009CA2712574A1 Polymorphic form of a [1,2,4]triazolo[4,3-a]pyridine derivative for treating inflammatory diseases
08/13/2009CA2711399A1 3-substituted sulfonylpiperidine derivative
08/12/2009EP2087908A1 Antibodies to opgl
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 1272